Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Triamcinolone for Trigeminal Nerve Block
NCT02024724Phase 4
Key facts
- Status
- Completed
- Start
- Nov 2013
- Primary completion
- Mar 2016
- Countries
- 1
- Sponsor
- Northwestern University
- Modality
- Orthosteric Ligands
- Conditions
- trigeminal neuralgia (TN)atypical facial pain (AFP)
01
Overview
Phase 4, randomised trial in trigeminal neuralgia (TN) and atypical facial pain (AFP) comparing Dexamethasone with Triamcinolone (2 arms). Primary endpoint: Proportion of Subjects Reporting at Least 50% Overall Pain Relief at 2 weeks. Started Nov 2013; status: completed.
02
Design
2 arms- Study design
- Randomized
Dexamethasone
4 mg Dexamethasone + 4 mL 0.25% Bupivacaine
Triamcinolone
40 mg Triamcinolone + 4 mL 0.25% Bupivacaine
03
Who it enrols
Patients presenting to the Northwestern Pain Center who are eligible and scheduled to receive a ultrasound-guided trigeminal nerve block.
04
Endpoints
Primary
Proportion of Subjects Reporting at Least 50% Overall Pain Relief
Secondary
Block Satisfaction
Beyond the preview
Go deeper on NCT02024724.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02024724.